Health Care & Life Sciences » Biotechnology | Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc.

Stellar Biotechnologies Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$7.46 M
Shares Outstanding
5.33 M
Public Float
4.53 M


332 East Scott Street
Port Hueneme California 93041
United States
Employees -
Updated 09/14/2018
Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded on June 12, 2007 and is headquartered in Port Hueneme, CA.


View All

Tessie Mary Che
Deborah F. Aghib
Independent Director